Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer.
Kush
K
Dalal
Mani
M
Roshan-Moniri
Aishwariya
A
Sharma
Huifang
H
Li
Fuqiang
F
Ban
Mohamed D
MD
Hassona
Michael
M
Hsing
Kriti
K
Singh
Eric
E
LeBlanc
Scott
S
Dehm
Emma S
ES
Tomlinson Guns
Artem
A
Cherkasov
Paul S
PS
Rennie